CClinicalTrials.gg
CompletedNCT01233700Updated Mar 2, 2022

Brief Intervention to Prevent Poor Psychosocial Outcomes in Living Donors

A Phase 2 interventional study of Motivational Interviewing and Healthy Lifestyles Education in Living Donation, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-02.

Sponsored by University of Pittsburgh · Phase 2, Interventional, and Prevention

Phase
Phase 2
Study type
Interventional
Enrollment
113
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the potential effectiveness of a psychosocial intervention based on the principles of motivational interviewing. The novel intervention will assist living donor candidates to think through any remaining concerns or questions that they may have about living donation. If the intervention is effective, it may help to prevent post-donation problems related to psychological and health outcomes.

Read the detailed description

The protection of living donors' well-being and the prevention of any negative consequences of donation are among the foremost priorities in transplantation. Some donors experience poor psychosocial outcomes after donation, including psychological distress, poor perceived physical well-being, and strained family relationships. No preventive interventions have been mounted or tested for their ability to avert poor psychosocial outcomes in living donors. The present study will provide an initial test of a new intervention for this purpose. The new intervention utilizes motivational interviewing (MI) to address remaining concerns that individuals may have about proceeding with living donation. Study participants will be randomly assigned to either (a) participate in the MI intervention (during which they will be asked to answer a series of questions to help them better delineate their reasons for and against proceeding with living organ donation), (b) participate in a comparison intervention designed to inform them about healthy lifestyle habits, or (c) not receive any intervention. We plan to recruit a maximum of 150 adults who are considering whether to serve as living kidney or liver donors. We hypothesize that participants receiving the MI intervention will have superior outcomes (less psychological distress, fewer physical health complaints, better interpersonal relationships within their family, better overall quality of life)after donation.

02

Conditions studied

  • Living Donation

Keywords

  • living donation
  • organ donation
  • psychological adaptation
  • mental health
  • physical well-being
  • interpersonal relations
  • quality of life
  • psychosocial factors
03

In context

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Score of 1 or greater on the Simmons Ambivalence Scale;
  • Must be able to speak English;
  • Have been evaluated as a potential living kidney or liver donor candidate;
  • Aged 18 or older
05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
113 participants (actual)

Study arms

  • Experimental
    Motivational Interviewing

    Subjects will receive two, individual telephone sessions with an interventionist, each lasting approximately 30-45 minutes. The sessions will focus on assisting subjects to delineate their reasons for or against proceeding with living organ donation and assisting subjects to resolve any lingering concerns about their decisions regarding donation.

    Behavioral: Motivational Interviewing

  • Active comparator
    Enhanced Standard Care

    Subjects will receive two individual telephone sessions with an interventionist, each lasting approximately 30-45 minutes. The sessions will focus on providing educational information to subjects regarding healthy lifestyle issues (healthy eating, diet, exercise, quitting smoking).

    Behavioral: Healthy Lifestyles Education

  • No intervention
    Standard Care

    Subjects will receive the standard care and education provided by the Living Donor Program at their medical center.

Interventions

  • BehavioralMotivational Interviewing

    Standard motivational interviewing techniques will be applied to assist subjects to consider and work to resolve any remaining concerns, doubts, or ambivalence about their decision about donating an organ to someone else.

  • BehavioralHealthy Lifestyles Education

    Educational information will be presented to subjects in didactic form on lifestyles issues of relevance to living donors.

06

What researchers measure

Primary outcomes

  1. psychological distress

    PRIME-MD depression and anxiety modules, Brief Symptom Inventory (BSI) anxiety items, Simmons Feelings About Donation items; Simmons Psychosocial Concerns About Donation items

    Time frame: 6 weeks post-donation

  2. somatic/physical health perceptions

    Concerns About Donation Effects items, Simmons Post-donation Medical Concerns, Brief Pain Inventory short form, FACIT-fatigue scale, Post-surgery Body Image Questionnaire, Post-donation Symptom Checklist, Simmons Concerns About Future Health items, Simmons Perceived Stressfulness of Donation items

    Time frame: 6 weeks post-donation

  3. interpersonal relationship quality and distress

    Simmons Family Relationship items, Short Dyadic Adjustment Scale, Family ICPS conflict and intimacy subscales

    Time frame: 6 weeks post-donation

  4. quality of life

    RAND-12

    Time frame: 6 weeks post-donation

  5. psychological distress

    PRIME-MD depression and anxiety modules, BSI anxiety items, Simmons Feelings About Donation items; Simmons Psychosocial Concerns About Donation items

    Time frame: 3 months post-donation

  6. somatic/physical health perceptions

    Concerns About Donation Effects items, Simmons Post-donation Medical Concerns, Brief Pain Inventory short form, FACIT-fatigue scale, Post-surgery Body Image Questionnaire, Post-donation Symptom Checklist, Simmons Concerns About Future Health items, Simmons Perceived Stressfulness of Donation items

    Time frame: 3 months post-donation

  7. interpersonal relationship quality and distress

    Simmons Family Relationship items, Short Dyadic Adjustment Scale, Family ICPS conflict and intimacy subscales

    Time frame: 3 months post-donation

  8. quality of life

    RAND-12

    Time frame: 3 months post-donation

Secondary outcomes

  1. Satisfaction with intervention

    adapted Client Satisfaction Scale

    Time frame: pre-donation (on average, 1 week post-intervention but before donation has occurred)

  2. Quality of decision to donate

    Simmons Ambivalence Scale items; Decision Conflict Scale, Decision Satisfaction Scale items

    Time frame: pre-donation (on average, 1 week post-intervention but before donation has occurred)

07

Study locations

1 site
  • University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213, United States
08

References and documents

Publications

  • Dew MA, DiMartini AF, DeVito Dabbs AJ, Zuckoff A, Tan HP, McNulty ML, Switzer GE, Fox KR, Greenhouse JB, Humar A. Preventive intervention for living donor psychosocial outcomes: feasibility and efficacy in a randomized controlled trial. Am J Transplant. 2013 Oct;13(10):2672-84. doi: 10.1111/ajt.12393. Epub 2013 Aug 7. PubMed 23924065 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01233700
Lead sponsor
University of Pittsburgh
Collaborators
National Institute of Nursing Research (NINR)
Responsible party
Mary Amanda Dew (Professor, University of Pittsburgh) — Principal investigator
First posted
Nov 3, 2010
Start date
Mar 2010
Primary completion
Apr 2013
Completion
Apr 2013
Last update
Mar 2, 2022

Study contacts

Mary Amanda Dew, Ph.D.
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion